Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2022.
Financials
Financial year 2025
Dr. Gert Cypers, Neurologie from Aalst, company number BE0501915711, closed financial year 2025 with a result of € 79,825 after tax. For that financial year Dr. Gert Cypers, Neurologie recorded a gross margin of € 162,941 and equity of € 289,507. Compared with financial year 2024, the result moved from € 111,156 to € 79,825. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 289,507
▼ 41% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 79,825
▼ 28% vs 2024
Profit after tax over the fiscal year.
€ 58,476
▼ 7% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 282,809 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 264
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,042
▲ 23% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 192,650
▲ 14% vs 2024
€ 24,547 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 7,012
▲ 207% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 12,350
▼ 13% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 163,914 | € 126,793 | € 184,531 | € 162,941 | ▼ 12% |
| Profit after taxes | € 64,559 | € 72,747 | € 111,156 | € 79,825 | ▼ 28% |
| Equity | € 331,190 | € 383,194 | € 492,490 | € 289,507 | ▼ 41% |
| Total debts | € 362,474 | € 265,372 | € 187,699 | € 276,599 | ▲ 47% |
| Cash | € 269,377 | € 365,908 | € 62,774 | € 58,476 | ▼ 7% |
| Land & buildings | € 255,329 | € 241,105 | € 324,716 | € 308,659 | ▼ 5% |
| Retained profit | € 318,790 | € 370,794 | € 480,090 | € 277,107 | ▼ 42% |
| Dividend | € 0 | € 20,743 | € 1,860 | € 282,809 | ▲ € 280,949 |
| Bank debt | € 199,637 | € 184,624 | € 169,437 | € 192,650 | ▲ 14% |
| Balance sheet total | € 693,664 | € 648,566 | € 680,189 | € 566,105 | ▼ 17% |
Key figures of Dr. Gert Cypers, Neurologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. Gert Cypers, Neurologie?
What happened at Dr. Gert Cypers, Neurologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 79,825 (▼ 28% vs 2024). filed late Source: NBB ↗
- Katrien Verheecke became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Aalst. KBO
- Gert Cypers became a director. NBB
In short
From € 64,559 profit in 2022 to € 79,825 profit in 2025.
Paid € 132,597 in corporate taxes since 2022.
Best year ever: 2024, with € 111,156 profit.
Paid out € 305,411 in dividends to the owners in total.
A new publication or filing at Dr. Gert Cypers, Neurologie? We notify you, reason included.
Follow Dr. Gert Cypers, NeurologieDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr. Gert Cypers, Neurologie are Gert Cypers and Katrien Verheecke.
Directors
According to the 2025 annual accounts
Gert Cypers
Director
since 2012
Katrien Verheecke
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Langestraat 18
9300 Aalst
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0501.915.711
- VAT number
- BE 0501.915.711
- Registered office
- Langestraat 18, 9300 Aalst
- Names & denominations
- Dr. Gert Cypers, Neurologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 December 2012
- Peppol
- Active · Active since 14 Aug 2026